Esperion Therapeutics Inc (ESPR) — Cash Flow Quality Index

Latest as of March 2024: 0.88x

Esperion Therapeutics Inc (ESPR) has a Cash Flow Quality Index of 0.88x as of March 2024. Operating cash flow of $53.83 Million is below net income of $61.02 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ESPR long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

0.88x

Operating CF / Net Income

Operating Cash Flow

$53.83 Million

USD

Net Income

$61.02 Million

USD

Data as of

Mar 2024

Most recent filing

Annual Cash Flow Quality Index for Esperion Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Esperion Therapeutics Inc. For live market cap and the full company financial profile, see ESPR company net worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.